Introduction
Sam68 (Src associated in mitosis; 68 kDa) is an RNAbinding protein belonging to the heterogeneous nuclear ribonucleoprotein K (hnRNP K) homology (KH) domain family of RNA-binding proteins. It also belongs to a subclass of KH domain-containing proteins, which have a single KH domain centered in a well-conserved region called the GSG (GRP33/Sam68/GLD-1) domain, also commonly referred to as the STAR (Signal Transduction and Activation of RNA metabolism) domain (Vernet and Artzt, 1997) . Sam68 is expressed in all tissues and its subcellular localization is predominantly nuclear (Wong et al., 1992 , McBride et al., 1996 . Nuclear localization of Sam68 requires both the Cterminus (containing its putative nuclear localization sequence) and the STAR/GSG domain (Chen et al., 1999) . McBride et al. (1998) demonstrated that ongoing transcription was required for diffuse nucleoplasmic distribution of Sam68. In the presence of transcriptional inhibitors, Sam68 was observed to be concentrated in heterogeneous spots within the nucleus (McBride et al. (1998) . A Sam68 mutant lacking the entire RNAbinding KH domain and a point mutant (G178E) unable to bind RNA also localized to nuclear dots (McBride et al., 1998) . Chen et al. (1999) demonstrated that Sam68 localized to novel nuclear structures, which they called SNBs (Sam68 Nuclear Bodies). These were shown to contain nucleic acid (RNA and/or DNA), but did not represent a site of active transcription (Chen et al., 1999) .
Sam68 was first characterized as a mitotic target for cSrc (Fumagalli et al., 1994; Taylor and Shalloway, 1994) , and as a tyrosine-phosphorylated protein associating with the T-cell-specific Src-family kinase p56lck (Vogel and Fujita, 1995) . Although its biological function is still not clear, a role for Sam68 in cell cycle progression was suggested by Liu et al. (2000) . They used retroviral-based random homozygous knockout antisense RNA strategy to decrease Sam68 protein levels in NIH3T3 cells, and showed that this resulted in neoplastic transformation (Liu et al., 2000) . The results implicated Sam68 as a potential tumor suppressor.
Recently, Taylor et al. (2004) reported that overexpression of Sam68 induced both cell cycle arrest and apoptosis in murine fibroblasts. Furthermore, Sam68 effects on cell cycle progression and cell death were separable functions dependent on its ability to bind RNA (Taylor et al., 2004) . They generated stable NIH3T3 cell lines having Sam68 expression controlled by an inducible promoter. Induction of Sam68 expression resulted in cell growth arrest at G1 phase of the cell cycle. They showed that cyclin D1 and E transcripts were downregulated upon Sam68 induction. An RNA-binding defective mutant was also capable of downregulating cyclin D1 and E transcript levels. They suggested that Sam68 was responsible for transcriptional repression of both cyclin D1 and E, and that this repression did not require Sam68 RNA-binding function (Taylor et al., 2004) . Interestingly, induced expression of Sam68 not only inhibited cell proliferation by repressing cyclin D1 and E expression but also induced apoptosis. Whereas inhibition of cyclin expression did not require its RNA-binding ability, Sam68-mediated apoptosis showed an absolute requirement for an intact RNA-binding function of Sam68 (Taylor et al., 2004) .
Recently, there has been an increase in the number of proteins reported to be modified by SUMO (small ubiquitin-like modifier). Initial reports describing sumoylation have defined two prerequisites for SUMO conjugation -a SUMO consensus sequence CKXE (where C is a large hydrophobic amino acid, K is the target lysine, X is any amino acid and E is glutamic acid) and a nuclear localization signal (Rodriguez et al., 2001) . The functional consequences of SUMO conjugation are quite diverse and appear to be substrate specific. SUMO conjugation has been reported to alter protein localization, protein activity, protein stability and protein-protein interactions (reviewed by Kim et al., 2002; Seeler and Dejean, 2003; Johnson, 2004) .
Sumoylation is a rapid and reversible post-translational modification. Covalent attachment of SUMO to a target protein is a multistep process similar to conjugation of ubiquitin (Kim et al., 2002; Johnson, 2004) . Unlike ubiquitin, there are at least three mammalian SUMO isoforms (SUMO-1, SUMO-2 and SUMO-3). SUMO-2 and SUMO-3 share 95% amino-acid sequence identity, and they both share about 47% sequence identity with SUMO-1. Like ubiquitin, only SUMO-2 and SUMO-3 can form poly-SUMO chains. There are three reported families of SUMO E3 ligase enzymes: the PIAS (protein inhibitor of activated STAT) proteins (1, 3, x and y), RanBP2 (Ran-binding protein 2) and Pc2 (Polycomb 2) (Mahajan et al., 1997 (Mahajan et al., , 1998 Matunis et al., 1998; Kotaja et al., 2002; Kagey et al., 2003; Johnson, 2004) . The ligases are localized to specific subcellular structures: PIAS with PML bodies and other nuclear bodies, RanBP2 with the nuclear pore complex and Pc2 with the Polycomb group bodies (Seeler and Dejean, 2003) . In a manner similar to SUMO ligases, SUMO proteases also exhibit specific subcellular localization properties (Jackson, 2001; Zhang et al., 2002; Melchior et al., 2003) . The compartmentalization of SUMO conjugating and deconjugation enzymes may regulate when and where a substrate is sumoylated.
Here we report that Sam68 can be SUMO modified, and demonstrate lysine 96 to be the main target for SUMO conjugation. Overexpression of the SUMO E3 ligase PIAS1 is shown to stimulate Sam68 sumoylation. Apoptosis induced by Sam68 expression was increased when the SUMO acceptor lysine was mutated to arginine. Fusion of SUMO-1 to Sam68, however, inhibited the ability of Sam68 to induce apoptosis. The SUMO-1 Sam68 fusion, but not the K96R Sam68 mutant, was a strong repressor of cyclin D1 expression.
Results
Sam68 is SUMO modified SUMO conjugation to a protein will induce a mobility shift of about 20 kDa on SDS-polyacrylamide gel electrophoresis (SDS-PAGE). To maintain SUMO attachment to a protein during the preparation of whole cell lysates, it is necessary to inactivate SUMO proteases. To detect Sam68 SUMO modification, 293T cells were lysed either by using mild lysis conditions (1% NP-40 lysis buffer) or by boiling in 2 Â SDS Laemmli sample buffer. Western blot analysis of the lysates with anti-Sam68 identified a band at 68 kDa and another minor band at approximately 88 kDa only when cells were lysed under strong denaturing conditions (2 Â SDS sample buffer) (Figure 1a ). To rule out the possibility that the 88 kDa band was an alternatively spliced form of Sam68 or a nonspecific crossreacting band, we examined if the Sam68-immunoreactive band was dependent on Sam68 expression. 293T cells were transfected with either empty vector or with Sam68 and lysed with 2 Â SDS Laemmli sample buffer. An Figure 1 A minor band at 88 kDa appears on anti-Sam68 Western blots. (a) 293T cells grown in a six-well plate were lysed with either 1% NP-40 lysis buffer or 2 Â SDS Laemmli sample buffer. Proteins were resolved by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotted with anti-Sam68 antibody. (b) 293T cells grown in a six-well plate were transiently transfected with either 5 mg of pCI empty vector or with 5 mg of Sam68. At 48 h posttransfection, cells were lysed in SUMO lysis buffer and boiled for 10 min. Proteins were resolved by SDS-PAGE and immunoblotted with anti-Sam68 antibody. (c) 293T cells were transiently transfected with Sam68. At 48 h post-transfection, cells were collected in phosphate-buffered saline (PBS) with or without 10 mM Nethylmaleimide (NEM) and lysed in 100 ml SUMO lysis buffer and boiled for 10 min. The lysate was diluted 1/10 with 1% NP-40 lysis buffer. Immunoprecipitation (IP) was with 1 mg of anti-Sam68 antibody (Ab) in the presence or absence of 10 mM NEM.
Immunoprecipitates were resolved by SDS-PAGE and immunoblotted with anti-Sam68 antibody.
SUMO modification of Sam68
I Babic et al anti-Sam68 Western blot of the lysates showed that the intensity of the 88 kDa band increased when Sam68 was overexpressed ( Figure 1b ). This suggested that the band was probably not a splice variant of Sam68 or a crossreacting band, as its appearance on an anti-Sam68 Western blot was dependent on Sam68 expression. The 88 kDa band could also be detected in Sam68 immunoprecipitates when N-ethylmaleimide (NEM), a sulfhydryl reagent commonly used to inhibit desumoylating enzymes, was included during immunoprecipitation. This suggested that it was a post-translationally modified form of Sam68 (Figure 1c) .
To determine if Sam68 could be modified by SUMO, and if the 88 kDa band was a sumoylated form of Sam68, 293T cells were transfected with either Sam68 alone or with hemagglutinin (HA)-tagged SUMO-1 or SUMO-2. At 48 h post-transfection, cells were lysed by boiling for 10 min in SUMO lysis buffer (62.5 mM Tris pH 6.8, 2% SDS). Western blot analysis of the lysates with anti-Sam68 antibody identified a band at approximately 90 kDa only when HA-tagged SUMO-1 or SUMO-2 was co-transfected with Sam68 ( Figure 2a ). As the HA tag provides a molecular weight shift of about 2 kDa, the 90 kDa band was most likely the 88 kDa band seen in previous blots. When the membrane was reprobed with anti-HA, the 90 kDa band was detected, suggesting that it was a SUMO-modified form of Sam68 (Figure 2a) . To demonstrate that endogenous Sam68 could be modified by SUMO, 293T cells were transfected with empty vector or HA-SUMO-1 and Sam68 immunoprecipitated from lysates prepared in 1% NP-40 lysis buffer. An anti-HA blot of the Sam68 immunoprecipitates detected a faint band at 90 kDa when HA-SUMO-1 was overexpressed (Figure 2b ).
K96 is the main SUMO acceptor site in Sam68
Analysis of Sam68 primary sequence revealed that lysine 96, which is the first lysine in the amino-terminal region of Sam68, is contained within a perfect SUMO consensus motif (Figure 3a and b) . Lysine 208 could also be a possible SUMO acceptor site. However, lysine 208 is preceded by a small hydrophobic amino acid (alanine) rather than a large hydrophobic amino acid (leucine, valine or isoleucine). Mutation of lysine 96, but not lysine 208, to arginine abrogated the appearance of the 90 kDa band when coexpressed with HA-tagged SUMO-1 (Figure 3c ). There was still some SUMO modification of the K96R mutant when it was coexpressed with SUMO-2 ( Figure 3c ). It is possible that SUMO-2 conjugation to Sam68 may not be solely restricted to lysine 96, whereas SUMO-1 conjugation to Sam68 appears to require lysine 96.
PIAS1 E3 SUMO ligase enhanced Sam68 sumoylation
There are currently three families of E3 SUMO ligases. The PIAS family of SUMO ligases have the most prevalent and diverse substrates (Jackson, 2001; Melchior et al., 2003) . Therefore, we chose to examine if PIAS1 could promote sumoylation of Sam68. We coexpressed Sam68 with HA-tagged SUMO-1 and the SUMO E3 ligase PIAS1. The presence of PIAS1 not only increased the appearance of the sumoylated 90 kDa Sam68, but also resulted in the appearance of an additional band at approximately 110-120 kDa, which might represent a doubly sumoylated form of Sam68 ( Figure 4 ). There have been reports describing the use of non-consensus SUMO sites when a SUMO target molecule was coexpressed with a SUMO E3 ligase (Miyauchi et al., 2002; Lee et al., 2003; Yamamoto et al., 2003) . We considered the possibility that there were other non-consensus sites potentially targeted for sumoylation. Lysine residues 134, 138, 139 and 208 were therefore mutated to arginine and each mutant was then coexpressed with HA-tagged SUMO-1 and PIAS1 in 293T cells. Each Sam68 mutant could still be SUMO modified (data not shown). Therefore, lysine 96 may be the only SUMO acceptor site in Sam68.
SUMO conjugation interferes with the ability of Sam68 to induce apoptosis Taylor et al. (2004) reported that induced expression of Sam68 could promote apoptosis in mouse fibroblasts. To examine the effect SUMO has on Sam68-mediated apoptosis, we transfected 293T cells with either green fluorescent protein (GFP) vector alone or GFP-tagged wild-type (WT) Sam68, K96R Sam68 or SUMO-1 Sam68 fusion, and measured apoptosis by Annexin V staining. Overexpression of K96R Sam68 was consistently more effective at inducing apoptosis than WT Sam68 (Figure 5a and b) . The SUMO-1 Sam68 fusion showed less of an induction of apoptosis than WT Sam68 (Figure 5b ). When monitoring apoptosis by examining cells for the presence of cleaved caspase-3 by anti-cleaved caspase-3 Western blot, overexpression of SUMO-1 Sam68 did not induce the appearance of cleaved caspase-3 to the same extent as WT or K96R Sam68 (Figure 6 ).
SUMO conjugated Sam68 represses cyclin D1 expression
It has been suggested that Sam68 may be a transcriptional repressor of cyclin D1 (Taylor et al., 2004) . Therefore, we examined if WT Sam68, K96R Sam68 or the SUMO-1 Sam68 fusion could influence the expression of a luciferase reporter gene driven by the cyclin D1 promoter. The reporter construct had 1291 bp of human cyclin D1 promoter containing 138 bp of the 5 0 -UTR cloned upstream of the firefly luciferase reporter gene in pGL3 plasmid (Promega, Madison, WI, USA). The reporter was coexpressed with HA-tagged Sam68 Figure 4 Sam68 sumoylation enhanced by PIAS1 SUMO ligase. 293T cells grown in a six-well plate were transfected with 1 mg of each construct as indicated. Total DNA used for transfection was equalized to 5 mg with pCI empty vector. At 48 h post-transfection, cells were lysed in 100 ml SUMO lysis buffer and boiled for 10 min. Proteins were resolved by SDS-polyacrylamide gel electrophoresis and immunoblotted with anti-Sam68 antibody. constructs or empty vector along with the b-galactosidase normalization vector LNCX (Clontech, Mountain View, CA, USA). Overexpression of the SUMO-1 Sam68 fusion protein significantly repressed expression of the cyclin D1 promoter luciferase reporter, whereas the K96R mutant was less effective than WT Sam68 in repression of the reporter (Figure 7 ). The K96R mutant showed some nonspecific repression of both the luciferase reporter gene construct and the LNCX normalization vector (b-galactosidase driven by a cytomegalovirus promoter), wheras the WT Sam68 only showed a minor repression of the normalization vector (data not shown). Interestingly, expression of the SUMO-1 Sam68 fusion protein did not show any repression of the normalization vector (data not shown).
To analyse if Sam68 overexpression could influence endogenous cyclin D1 levels, NIH3T3 cells were transfected with GFP or GFP-tagged WT Sam68, K96R mutant Sam68 or the SUMO-1 Sam68 fusion, then synchronized in mitosis with nocodazole and subsequently released into G1 by washout. Green fluorescent protein-expressing cells were sorted 16 h later, RNA isolated and reverse transcriptase -PCR (RT-PCR) performed for cyclin D1 and glyceraldehyde-3-phosphate dehydrogenase (GAPDH). Figure 8 shows that overexpression of WT Sam68 and SUMO-1 Sam68 resulted in decreased cyclin D1 transcript levels relative to control GAPDH transcript. Overexpression of K96R Sam68 did not appear to have an effect on endogenous cyclin D1 transcript levels (Figure 8 ).
Discussion
Post-translational modifications are important regulators of Sam68 function. Tyrosine phosphorylation negatively regulates its ability to bind homopolymeric poly(U) RNA (Wang et al., 1995; Derry et al., 2000) , whereas acetylation positively regulates poly(U) RNA binding (Babic et al., 2004) . Serine/threonine phosphorylation was also shown to regulate Sam68 function in alternative RNA splicing (Matter et al., 2002) . Here we Figure 7 SUMO-1 Sam68 fusion is a strong specific repressor of a cyclin D1 promoter luciferase reporter construct. 293T cells in a 12-well dish were co-transfected with 0.4 mg of hemagglutinin (HA) vector alone, or HA-wild-type (WT) Sam68, or HA-K96R Sam68 or HA-SUMO-1 Sam68 fusion along with 0.4 mg of the cyclin D1 promoter luciferase reporter and 0.2 mg of LNCX normalization vector. At 24 h post-transfection, cells were lysed in 1 Â luciferase assay lysis reagent. Protein concentration was equalized for each sample and 20 ml of each lysate was used for luciferase assay and 2 ml used for b-galactosidase assay. The relative light units for the luciferase assay were adjusted to normalize for transfection efficiency and nonspecific effects on expression of the normalization vector. Values determined for vector alone were set to 100%. Error bars for WT and K96R Sam68 represent the standard deviation from four independent experiments, and the error bars for the SUMO-1 Sam68 fusion represent the standard deviation from three independent experiments. Data were analysed for statistical significance using one-way ANOVA followed by a post hoc Tukey HSD test (**Po0.01 vs other groups). Figure 6 Conjugation of SUMO-1 to Sam68 inhibits its ability to induce apoptosis. 293T cells grown in a six-well plate were transfected with 5 mg of either GFP-WT Sam68, GFP-K96R Sam68 or GFP-SUMO-1 Sam68. At 48 h post-transfection, cells were lysed by boiling for 10 min in SUMO lysis buffer. Proteins were resolved by SDSpolyacrylamide gel electrophoresis and immunoblotted with anticleaved caspase-3 and anti-GFP. Figure 8 Expression of wild-type (WT) or SUMO-1 conjugated Sam68, but not K96R mutant Sam68, inhibits accumulation of endogenous cyclin D1 transcript. NIH3T3 cells transfected with green fluorescent protein (GFP), GFP-WT Sam68, GFP K96R Sam68 or GFP-SUMO-1 Sam68 were synchronized in mitosis by nocodazole. At 16 h after release from mitosis, cells were sorted for GFP expression, RNA isolated and cyclin D1 and glyceraldehyde-3-phosphate dehydrogenase transcript levels determined by reverse transcriptase-PCR.
SUMO modification of Sam68 I Babic et al report that Sam68 can also be post-translationally modified by both SUMO-1 and SUMO-2. The main acceptor site for SUMO was found to be lysine 96, the first lysine in the amino-terminal domain of Sam68. The E3 SUMO ligase PIAS1 was shown to stimulate Sam68 sumoylation (Figure 4) . It is possible that other E3 SUMO ligases could also stimulate Sam68 sumoylation.
Overexpression of Sam68 in fibroblasts was previously reported to inhibit accumulation of cyclin D1 and E transcripts, and it was suggested that Sam68 may act as a transcriptional repressor of cyclin D1 (Taylor et al., 2004) . Other reports have also implicated Sam68 as a transcriptional repressor. Hong et al. (2002) reported that Sam68 demonstrated potent transcriptional repression of a co-transfected reporter construct independent of its RNA-binding activity (Hong et al., 2002) . A Sam68-Gal4 fusion repressed the expression of a Gal4-binding site-containing reporter plasmid. Therefore, direct recruitment of Sam68 to a promoter region resulted in strong transcriptional repression. Mutation of the RNA-binding domain of Sam68 had no influence on Sam68 ability to repress transcription (Hong et al., 2002) . Thus, its ability to act as a negative regulator of transcription was independent of its RNA-binding function. This is consistent with the report by Taylor et al. (2004) showing Sam68 inhibition of accumulation of cyclin D1 transcript. Interestingly, we observed enhanced repression of a cyclin D1 promoter luciferase reporter construct with overexpression of the SUMO Sam68 fusion (Figure 7) . Furthermore, we observed that SUMO conjugated Sam68 was an effective inhibitor of accumulation of endogenous cyclin D1 transcript levels (Figure 8) . Mutation of the SUMO acceptor lysine to arginine abrogated the ability of Sam68 to inhibit cyclin D1 transcript accumulation (Figure 8 ). Therefore, Sam68 may need to be SUMO modified for it to function as a transcriptional repressor.
There have been numerous reports describing SUMO conjugation as a mechanism for negatively regulating transcriptional activity (reviewed by Gill, 2003 Gill, , 2005 Verger et al., 2003) . It was suggested that transcriptional repression induced by sumoylation may involve differences in protein-protein interactions (Gill, 2003 (Gill, , 2005 Verger et al., 2003) . In fact, SUMO conjugation may inhibit proteins from binding to transcriptional coactivators such as histone acetyltransferases, and may instead mediate an interaction with histone deacetylases (HDACs) (Gill, 2003 (Gill, , 2005 Verger et al., 2003) . Yang and Sharrocks (2004) recently reported that transcriptional repression by SUMO-modified Elk-1 transcription factor was mediated by recruitment of HDAC2. Also, Girdwood et al. (2003) demonstrated that coactivator CBP/p300 transcriptional repression was mediated by SUMO modification. Furthermore, they showed that repression resulted from an association between the sumoylated form of p300 and HDAC6. We and others have previously reported that Sam68 can associate with the acetyltransferase CBP (Hong et al., 2002; Babic et al., 2004) . Conjugation of SUMO to Sam68 might function to alter its affinity for coactivators such as CBP and may promote association with other molecules such as HDACs.
Sam68 has been implicated in several biological processes (reviewed by Lukong and Richard, 2003) such as signal transduction, cell cycle progression, viral gene expression, RNA transport and translation, alternative RNA splicing, transcriptional regulation and recently apoptosis. Barlat et al. (1997) were the first to report that Sam68 may function as a regulator of cell cycle progression. Furthermore, they identified a splice variant of Sam68 lacking the KH domain that could inhibit cyclin D1 expression and induce growth arrest. Interestingly, a potential SUMO consensus motif is introduced at the splice junction of this splice variant (amino acids 168-171 (PKEE)). Expression of WT Sam68 having an intact RNA-binding domain could mediate cell cycle progression and overcome growth arrest induced by the splice variant (Barlat et al., 1997) . Li et al. (2002) also suggested a role for Sam68 in promoting cell cycle progression. They had isolated a chicken DT-40 B cell line in which the expression of the endogenous sam68 gene was disrupted, and showed that Sam68 deficiency resulted in decreased cell growth rate. Together, these reports strongly suggested a role for Sam68 as a mediator of cell cycle progression. However, this is in contrast to the reports by Liu et al. (2000) and Taylor et al. (2004) , which implicate Sam68 as a potential tumor suppressor and inhibitor of cell cycle progression. We present evidence in this report to suggest that Sam68 may have different functions on cell growth depending on which post-translational modifications are present. We propose a model whereby sumoylated Sam68 can function as a transcriptional repressor of cyclin D1, ultimately resulting in G1 arrest (Figure 9 ). The non-sumoylated pool of Sam68 representing the majority of Sam68 within the cell may have other functions, one of which is induction of apoptosis requiring RNAbinding capability (Figure 9 ). Taylor et al. (2004) showed the RNA-binding domain was necessary for Sam68 induction of apoptosis. As well, they showed an increase in apoptosis when cells were treated with a deacetylase inhibitor, thus promoting acetylation. We have reported that Sam68 binding to RNA is enhanced when it is acetylated (Babic et al., 2004 ). An increase in Sam68 RNA binding through acetylation may therefore result in an increase in apoptosis-inducing proteins. However, if Sam68 is tyrosine phosphorylated by kinases, such as Src or BRK, then the ability of Sam68 to bind RNA may be inhibited. Lukong et al. (2005) recently reported that the transformation ability of BRK involves tyrosine phosphorylation of Sam68. Tyrosine phosphorylation of Sam68 may have a role in promoting cell proliferation possibly by inhibiting Sam68 affinity for RNA and stimulating its function as a signaling adaptor molecule. Whether SUMO influences Sam68 binding to physiological RNA substrates is still unclear. However, the sumoylated form of Sam68 can associate with poly(U) RNA, although it binds less than K96R Sam68 (data not shown). If Sam68 is acting as a transcriptional repressor, it may be important to examine if SUMO can alter Sam68 affinity for DNA. Sumoylation of the heat shock transcription factor 2 (HSF2) was shown to enhance its affinity for DNA (Desterro et al., 1998) .
For several transcriptional regulators, the sumoylation site maps to known repressor domains or to 'synergy control' motifs (Iniguez-Lluhi and Pearce, 2000) . Synergy control motifs play a role in amplifying transcriptional output when present at multiple sites on a promoter target region (Holmstrom et al., 2003) . Sam68 may contain a transcriptional repressor domain centered on lysine 96. Mutation of this lysine can inhibit Sam68 ability to act as a transcriptional repressor of a cyclin D1 promoter luciferase reporter (Figure 7) . Interestingly, lysine 96 is localized within a synergy control motif as defined by the presence of proline residues within 0-3 amino acids at either or both ends of the core sumoylation motif (Holmstrom et al., 2003) . Therefore, the sequence 95-VKMEP-99 of Sam68 represents not only the main target for sumoylation, but also a potential synergy control motif.
RNA-binding proteins that function as transcription factors are not uncommon. For example, the KH domain-containing RNA-binding protein hnRNP K also has been demonstrated to be a DNA-binding transcriptional activator of the c-myc gene (Tomonaga and Levens, 1995; Michelotti et al., 1996) . Another RNA-binding protein shown to be a transcription factor is far upstream-binding protein (FBP), which can interact with the far upstream element (FUSE) of the human c-myc gene (Duncan et al., 1994) . This protein, like Sam68 and hnRNP K, contains an RNA-binding KH domain. Sam68 and hnRNP K have been shown to associate in vivo, and both are wellcharacterized substrates for Src kinase (OstareckLederer et al., 2002; Yang et al., 2002) . In fact, Yang et al. (2002) reported that hnRNP K significantly inhibited Sam68-mediated, but not Rev-mediated, RRE-dependent gene expression. As well, Sam68 was shown to inhibit the transcriptional activity of hnRNP K (Yang et al., 2002) . Interestingly, hnRNP K also has a consensus SUMO site embedded within a possible synergy control motif. It is still unknown if the transcriptional activity of Sam68 is dependent on its interaction with hnRNP K.
Induction of apoptosis by the K96R Sam68 mutant was slightly enhanced compared to WT Sam68 ( Figure  5a and b) . Taylor et al. (2004) reported that Sam68 RNA-binding function was required for its ability to promote cell death. It will be important to determine if the K96R mutant displays increased affinity for cellular RNA targets. K96R Sam68 only showed a slight increase in binding to poly(U) RNA compared to WT Sam68 (data not shown). Unfortunately, the physiological RNA substrate(s) for Sam68 are not well established, but an examination of its association with transcripts of apoptotic genes may be warranted. SUMO fusion to Sam68 inhibited its ability to induce apoptosis (Figure 6 ), and may act by negatively regulating its affinity for RNA targets. Vassileva and Matunis (2004) were the first to report that some RNAbinding proteins were modified by SUMO and suggested that SUMO conjugation and deconjugation may play a significant role in the nucleocytoplasmic transport of mRNPs. They identified hnRNP M and hnRNP C as two SUMO-modified proteins localized to the nuclear pore complex (NPC), and suggested that SUMO conjugation of these proteins at the NPC might act to facilitate the release of mRNP cargo allowing transit of the mRNA through the NPC to the cytoplasm (Vassileva and Matunis, 2004) . In a similar way, SUMO conjugation to Sam68 may have a role in preventing Sam68 association with its RNA target(s).
Materials and methods

Cell culture and transfections
Human renal 293T cells were maintained in Dulbecco's modified Eagle's medium (Gibco BRL Carlsbad, CA, USA) supplemented with 10% fetal bovine serum, 500 U/ml penicillin and 0.5 mg/ml streptomycin, at 371C in a humidified chamber at 5% CO 2 . Transfection of cells was performed with LipofectAmine 2000 (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions. 
Plasmids and mutagenesis
The HA-SUMO-1 and HA-SUMO-2 expression constructs were kindly provided by Dr K Orth (University of Texas Southwestern Medical Center, Dallas). The PIAS1 expression construct was kindly provided by Dr J Tan (University of North Carolina, Chapel Hill). The cyclin D1 promoter luciferase reporter was kindly provided by Dr K Riabowol (University of Calgary). The Sam68 clone used for overexpression was originally isolated from a human T-lymphocyte cDNA library (Babic et al., 2004) . To mutate specific residues within Sam68, the QuikChanget Site-Directed Mutagenesis kit (Stratagene, La Jollan CA, USA) was used according to the manufacturer's instructions. The entire Sam68 cDNA was sequenced to confirm the presence of only the directed mutation(s).
Cell lysis, immunoprecipitation and Western blot analysis
For analysis of SUMO-modified protein cells grown in a sixwell plate were lysed by first lifting the 293T cells with 5 ml room temperature phosphate-buffered saline (PBS) by pipetting up/down. The cells were pelleted, PBS was aspirated off, the cell pellet was disrupted by mixing and cells lysed by adding 100 ml of SUMO lysis buffer (62.5 mM Tris pH 6.8, 2% SDS) and boiling for 10 min. The samples were centrifuged for 10 min at full speed in an eppendorf microcentrifuge. The supernatant was transferred to a new tube and either stored at À801C until required for further analysis or used for protein determination.
Immunoprecipitation (IP) was from lysates prepared with 1% NP-40 lysis buffer (1% NP-40, 25 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM EDTA) with inhibitors (1 mM Na 3 VO 4 , 1 mM PMSF, 2 mg/ml leupeptin, 2 mg/ml aprotinin, 2 mg/ml pepstatin, 25 mM NaF, 10 mM pNPP) with or without 10 mM NEM. A 1 mg portion of the IP antibody was added and the samples placed on ice for 1 h. Then, 30 ml of a 50% solution of protein A/G Plus (Santa Cruz Biotechnology Inc.) was added and the mixture incubated on a rotator at 41C for 2 h. Immunoprecipitates were washed three times with IP buffer and resuspended in 2 Â Laemmli sample buffer, boiled for 5 min and resolved by SDS-PAGE. Antibodies used for either IP or Western blot analysis were anti-Sam68 polyclonal (C-20) antibody (Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA), anti-HA monoclonal antibody (262K) (Cell Signaling Technology), anti-tubulin monoclonal antibody (Ab-1) (Oncogene Research Products, San Diego, CA, USA), anti-cleaved caspase-3 (Asp175) monoclonal antibody (Cell Signaling Technology, Beverly, MA, USA) and anti-GFP (Santa Cruz Biotechnology Inc.). Western blots were developed using Enhanced Chemiluminescence detection reagents (Amersham, Piscataway, NJ, USA) according to the manufacturer's instructions.
Construction of HA-tagged Sam68 expression vectors
To generate HA-tagged Sam68 constructs, the following sense and antisense oligonucleotides were synthesized by the University of Calgary Oligonucleotide Synthesis Laboratory:
The oligonucleotides corresponded to the influenza HA epitope tag to be fused in-frame upstream of the first codon of the Sam68 cDNA sequence. The oligonucleotides were annealed, which resulted in a 5 0 overhanging Nhe1 site and a 3 0 overhanging EcoR1 site. The annealed fragment was then ligated into Nhe1/EcoR1 double-digested pCI-WT Sam68 and pCI-K96R mutant Sam68 expression constructs. The resulting encoded Sam68 had the following 15 amino acids at the amino-terminus just upstream of the first methionine residue of Sam68: NH 2 -MAYPYDVPDYAKFTTy (the sequence encoding the influenza HA epitope tag is underlined).
Construction of HA-SUMO-1 Sam68 fusion expression construct To generate a SUMO-1-tagged Sam68 construct, WT HAtagged Sam68 was first used as a template in site-directed mutagenesis using the QuikChanget Site-Directed Mutagenesis kit (Stratagene). The nucleotides encoding lysine 96 were replaced by nucleotides corresponding to both an Apa1 restriction site and a Kpn1 restriction site. The following mutagenic primer set was used:
The nucleotides underlined represent the inserted sequence at amino-acid position 96. The entire Sam68 cDNA was sequenced to confirm the presence of only the insertion. The Apa1/Kpn1-containing Sam68 construct was then digested sequentially with Apa1 and Kpn1. To generate the SUMO-1 sequence at position 96, human SUMO-1 was PCR amplified using the sense primer 5 0 -AGTGGGCCCATGTCTGACCAGGAGGC-3 0 (the Apa1 site is underlined and the start codon is bold) and the antisense primer 5 0 -ATCGGTACCCGTCTGCTGTTG-3 0 (the Kpn1 site is underlined and amino acid 95 of the SUMO-1 sequence is in bold). The last amino acid of the amplified SUMO-1 to be inserted into Sam68 was engineered to be amino acid 95, which is just before the glycine-glycine motif (amino acids 96 and 97) recognized by SUMO isopeptidases. The resulting PCR fragment was then digested with Apa1 and Kpn1 and ligated into the Apa1/Kpn1-digested mutant HA-Sam68. Sequencing confirmed that the SUMO-1 fusion was in-frame. The protein encoded from the resulting HA-tagged SUMO-1 Sam68 fusion construct had the 15 amino acids with the HA tag at the aminoterminus just before the first methionine residue of Sam68, and had amino-acid residues 1-95 of the human SUMO-1 inserted in-frame between Sam68 valine 95 and methionine 97. Cloning also introduced an Apa1 site just before the SUMO insertion and a Kpn1 immediately after the SUMO insertion. These introduced restriction sites encode a glycine and a proline between Sam68 valine 95 and SUMO amino acid 1, and a glycine and a threonine between SUMO amino acid 95 and Sam68 methionine 97.
Construction of EGFP-tagged Sam68 expression vectors
To generate in-frame EGFP-tagged Sam68 constructs, the pCI-WT Sam68 or -K96R Sam68 or -SUMO-1 Sam68 expression vectors were first used as a template in PCR with the sense primer 5 0 -TGAATTCTATGCAGCGCCGGGAC GA-3 0 (the EcoRI site is underlined and the start codon is bold) and the antisense primer 5 0 -CGGGTCGACTTACA CAGTGGCACC-3 0 (the SalI site is underlined and the stop codon is in bold). The 1.4 kb PCR fragment was then restriction digested with EcoRI and SalI. This was then ligated into EcoRI and SalI-digested pEGFP-C1DNA vector (Clontech). Clones with the insert were sequenced to confirm Sam68 was fused in-frame to EGFP and that no other mutations were present.
Apoptosis assay 293T cells in a six-well dish transfected with either GFP, GFP-WT Sam68, GFP-K96R Sam68 or GFP-SUMO-1 Sam68 were harvested 48 h post-transfection by pipetting media (3 ml) up/ down and 1 ml (approximately 2 Â 10 6 cells) transferred to an eppendorf tube and spun at 3000 r.p.m. for 5 min. For Annexin V-PE labeling, cells were incubated with PE-conjugated Annexin V (BD Pharmingen, San Jose, CA, USA) according to the manufacturer's instructions. Briefly, cells were washed once with 1 ml PBS and the pellet then resuspended in 200 ml of binding buffer. Annexin V-PE was added to a final concentration of 1 mg/ml and incubated with the cells in a final volume of 500 ml at room temperature for about 10 min in the dark before flow cytometric analysis.
Luciferase assay 293T cells in a 12-well plate were transfected as described, and 24-48 h post-transfection, media were aspirated off and the cells washed with 2 ml PBS. The PBS was then removed and cells lysed by adding 80 ml of 1 Â Luciferase assay lysis reagent (Promega) equilibrated to room temperature. After 1 min lysis, the lysate was pipetted up/down several times to further lyse the cells and then transferred to eppendorf tubes. The eppendorf tubes were then vortexed for 15 s and placed at À801C for 30 min or stored for use at a later time. The cells were then thawed rapidly at 371C and spun at high speed in an eppendorf microfuge for 3 min. The supernatant was transferred to a new tube and placed on ice. The amount of protein in the lysate was then determined by Bradford assay and samples equalized to the same protein concentration. For the luciferase assay, 20 ml of supernatant was added to a 5 ml polystyrene round-bottom tube (BD Biosciences, San Jose, CA, USA) and 100 ml of reconstituted Lucifease assay substrate reagent (Promgea) was then added and the samples mixed gently by shaking. The tube was immediately placed in a Monolight 2000 Luminometer (Analytical Luminescence Laboratory, San Diego, CA, USA) and luminescence detected over 30 s with a 2 s delay. Luminescence detected from a lysate control in which cells were transfected with empty vector alone without the luciferase reporter was subtracted from all samples. To normalize the results from the luciferase assay for variations in transfection efficiency, the cells were cotransfected with the LNCX (Clonetech) b-galactosidase expression vector.
Cyclin D1 RT-PCR NIH3T3 cells grown in 10 cm dishes were transfected with either GFP empty vector, GFP-WT Sam68, GFP-K96R Sam68 or GFP-SUMO-1 Sam68. At 24 h post-transfection, cells were synchronized in mitosis by adding nocodazole to a final concentration of 500 ng/ml. After 16 h, mitotic cells were collected by shake-off and nocodazole removed by washing three times with media. Cells were then re-plated in 10 cm dishes and 24 h later GFP-expressing cells were sorted by flow cytometry. GFP-sorted cells were pelleted and RNA was isolated using the RNeasy Mini Kit (Qiagen). A 900 ng portion of RNA was used for RT-PCR using the Qiagen One-Step RT-PCR kit according to the manufacturer's instructions. Primers for PCR were as follows: cyclin D1 5 0 -AGCCATG GAACACCAGCTCCTGTG-3 0 and 5 0 -CTTAGAGGCCAC GAACATGCAGG-3 0 ; GAPDH 5 0 -CGGCACAGTCAAGG CCGAGAATGG-3 0 and 5 0 -GGTCATGAGCCCTTCCACA ATGCC-3 0 . Reverse transcriptase-PCR conditions were 30 min at 501C, 15 min at 951C, 23 cycles (cyclin D1) or 18 cycles (GAPDH) of 1 min at 941C, 1 min at 551C and 1 min at 721C, followed by a final extension of 10 min at 721C. Onesixth of the RT-PCR reactions were separated on a 1% agarose gel and viewed by ethidium bromide staining.
